Healthcare Professional Site | OPDIVO® (nivolumab)

- pd-l1test.com

Learn about OPDIVO® for patients with Previously Treated Metastatic Squamous and Non-Squamous Non-Small Cell Lung Cancer (NSCLC). Please see Indication and Important Safety Information.

Not Applicable $ 8.95